Concepedia

Tariq Muzzafar

TM

Statistics

Publications

22

Citations

1.6K

H-Index

18

Active since

2005

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Rush University

Central South University

University of Chicago

Tariq Muzzafar is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and lymphoid neoplasms.

ORCID

Publications per year

2005–2018

22

Publications

22

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial

Jason R. Westin, Fuliang Chu, Min Zhang et al. · The Lancet Oncology · 2013 · 530 citations

, , +13

Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial

Nathan Fowler, R. Eric Davis, Seema Rawal et al. · The Lancet Oncology · 2014 · 263 citations · Full text

, , +12

Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study

Mohamed A. Kharfan‐Dabaja, Monzr M. Al Malki, Uday Deotare et al. · British Journal of Haematology · 2017 · 83 citations · Full text

, , +13

A pituitary carcinoma secreting TSH and prolactin: a non-secreting adenoma gone awry

Rebecca Brown, Tariq Muzzafar, Robert Wollman et al. · European Journal of Endocrinology · 2006 · 71 citations · Full text

, , +17

Non‐anaplastic peripheral t‐cell lymphoma in childhood and adolescence: A Children's Oncology Group study

R. Hutchison, Joseph Laver, Myron Chang et al. · Pediatric Blood & Cancer · 2008 · 69 citations

, , +10

1–5 of 22